Rose C. Perri serves as Executive at GENEREX BIOTECHNOLOGY CORP, where they oversee executive responsibilities. Since joining the company, Rose C. Perri has executed 9 insider transactions totaling $42.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 9, 2011 involved selling 15,000 shares valued at $3.5K.
Rose C. Perri currently holds 975,478 shares of GENEREX BIOTECHNOLOGY CORP (GNBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rose C. Perri has been a net buyer of GNBT stock. They have purchased $28.5K and sold $13.6K worth of shares.
Rose C. Perri's most recent insider trade was on May 9, 2011, when they sold 15,000 shares at $0.23 per share.
Get notified when new Form 4 filings are submitted
| $0.23 |
| Discretionary |
| May 3, 2011 | GNBT | $5.5K | Sale | 25,000 | $0.22 | Discretionary |
| Jan 3, 2011 | GNBT | $0 | Option Exercise | 576,752 | $N/A | Discretionary |
| Oct 27, 2010 | GNBT | $18.9K | Purchase | 54,000 | $0.35 | Discretionary |
| Nov 16, 2009 | GNBT | $5.1K | Purchase | 10,000 | $0.51 | Discretionary |
| Oct 13, 2008 | GNBT | $1.2K | Purchase | 3,800 | $0.31 | Discretionary |
| Oct 13, 2008 | GNBT | $3.4K | Purchase | 11,200 | $0.30 | Discretionary |
| Aug 17, 2007 | GNBT | $0 | Award | 175,000 | $N/A | Discretionary |